RATIOPHARM ApS: Financial statements 2012
CVR: 25762290
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
RATIOPHARM ApS (CVR 25762290) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 456,801 and a net result of DKK 513,740. Equity in the 2012 report amounted to DKK 15,875,409. The solvency ratio was 95.1%.
- Gross Profit
- DKK 456,801
- Profit/Loss
- DKK 513,740
- Equity
- DKK 15,875,409
- Total Assets
- DKK 16,690,798
Official annual report
Keep an eye on RATIOPHARM ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of June 4, 2012, Kim Vallentin Peetz is registered as direktion of RATIOPHARM ApS.
As of June 4, 2012, Peter Mikael Burestedt is registered as direktion of RATIOPHARM ApS.
As of June 4, 2012, Lone Juul Darket has stepped down as direktion of RATIOPHARM ApS.
As of June 4, 2012, Emile Gérardus Wilhelmus Hendr icus Loof has stepped down as direktion of RATIOPHARM ApS.
About RATIOPHARM ApS
RATIOPHARM ApS was a Danish company of the type Anpartsselskab based in Kgs.Lyngby, founded in 2000. The company has been dissolved on 21 May 2015. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 0 employees (2011). In 2013, the company reported a gross profit of DKK 328,503 and a net result of DKK 95,633 compared with DKK 513,740 the year before. Equity in the 2013 report amounted to DKK 1,816,042.